Closure of ostium secundum atrial septum defect with the Atriasept occluder: Early European experience

Stolt, Valérie; Chessa, Massimo; Aubry, P; Juliard, Jean Michel; Schraeder, Rainer; Berger, Alexandre; Goy, J.‐J.

doi:10.1002/ccd.22394

Cited by 17 publications

(6 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[7,8] A recent multicenter study has tested the efficacy and safety of the new Atriasept ASD occluder for secundum ASD closure. [5] A 90% clinical success rate was achieved (71 out of 79 patients) with low morbid- ity and no mortality. Of the reported patients, 10 had a large ASD (>20 mm) which was closed successfully with the Atriasept ASD occluder.…”

Section: Discussionmentioning

confidence: 84%

See 1 more Smart Citation

Obstruction of superior vena cava flow during transcatheter atrial septal defect closure with the Atriasept ASD occluder

2013

Arch Turk Soc Cardiol

View full text Add to dashboard Cite

In this paper, we describe a patient with a large secundum atrial septal defect ASD (26 mm) with adequate rims that were suitable for percutaneous closure. While closing this ASD, the superior vena cava (SVC) was occluded with the right atrial disc of the Atriasept ASD occluder (Cardia) and thus the device was retrieved before its release. After retrieval of this device, an Amplatzer ASD occluder was successfully implanted without disturbing the caval flow.

show abstract

Section: Discussionmentioning

confidence: 84%

“…[4] It is fully retrievable and has a self-centering design. [5] Using standard techniques, the device was inserted and deployed under fluoroscopic and transesophageal echocardiogram (TEE) guidance ( Fig. 1a, Video 1*).…”

Section: Case Reportmentioning

confidence: 99%

Obstruction of superior vena cava flow during transcatheter atrial septal defect closure with the Atriasept ASD occluder

2013

Arch Turk Soc Cardiol

View full text Add to dashboard Cite

show abstract

“…Près de 50% des enfants de la série nous ont été adressés pour le suivi cependant les affections respiratoires (25%) et l'insuffisance cardiaque (20%) sont restées des motifs fréquents d'admission comme ça a été le cas lors d'études précédentes menées au Sénégal et au Maroc [3, 14]. En Europe, avec plus de moyens de diagnostic et de prise en charge, on retrouve rarement des cas de CIA en insuffisance cardiaque [11, 18].…”

Section: Discussionunclassified

Les communications interauriculaires chez l’enfant: diagnostic et prise en charge à propos de 49 cas aux CHU pédiatriques de Dakar

Basse

Fall

Seck³

et al. 2018

Pan Afr Med J

View full text Add to dashboard Cite

La communication interauriculaire (CIA) constitue la seconde cardiopathie congénitale la plus importante chez l'enfant, elle représente 6 à 8% des malformations congénitales cardiaques de l'enfant. Toutefois, de nombreuses questions demeurent ouvertes concernant cette pathologie. Ainsi notre objectif était de rapporter la prévalence hospitalière des CIA mais surtout d'en décrire les aspects cliniques, paracliniques et thérapeutiques. Pour y parvenir nous avons réalisé une étude rétrospective descriptive. Les données ont été recueillies grâce à un questionnaire puis saisies et analysées sur Sphinx (V5). La prévalence hospitalière était de 2 pour 1000. L'âge moyen était de 37mois et le sex-ratio de 0,75. Il n'y a eu aucun cas diagnostiqué en anténatal. Une consanguinité parentale était retrouvée dans 30% des cas. Les infections respiratoires étaient présentes dans 24% des cas. Une cardiomégalie était retrouvée dans 35 cas avec une hyper vascularisation pour 63%. L'échographie notait une prédominance du type ostium secundum; la CIA était large dans 63% des cas. La sténose pulmonaire représentait l'atteinte cardiaque associée la plus importante. L'HTAP était présente dans 63% des cas. Les diurétiques étaient très utilisés et seuls 7 enfants avaient bénéficié d'une cure chirurgicale. L'évolution était favorable chez 39 patients soit 79%. Le diagnostic précoce des CIA doit être amélioré ainsi que la prise en charge chirurgicale des formes avec retentissement du nourrisson.

show abstract

“…A multicenter European study of 75 successful implantations, however, has not shown clinical signs of such complications; one patient had only a mild, transient pericardial effusion post-implantation. The 64 patients who completed 6-month follow-up showed no device migration, perforation, or thrombi [65]. The Atriasept II was improved using a round left disk and no wire arm, but aortic perforations and PVA coating malfunctions continued to be reported [66,67].…”

Section: Cardia Atriasept I/ii and Ultracept I/iimentioning

confidence: 94%

Historical developments of atrial septal defect closure devices: what we learn from the past

Nassif

Abdelghani

Bouma

et al. 2016

Expert Review of Medical Devices

View full text Add to dashboard Cite

Introduction: Since King and Mills' pioneering work in percutaneous closure devices of secundum atrial septal defects (ASD) four decades ago, developments in device shape, material and implantation technique led to adoption of percutaneous ASD closure as current treatment of choice. Not only was the feasibility of such a percutaneous procedure tested altogether, but pursuing the ideal device in terms of safety and efficacy became priority. Areas covered: In this review we present the historical development of ASD devices in design, material and technique with clinical data, and provide the future perspectives in percutaneous ASD closures. Expert opinion: An 'ideal device' requires complete defect closure with negligible risk of complications using a safe, straightforward delivery technique with repositioning and retrieving properties. Some of the devices currently at hand come close to fulfilling these criteria, however none seem to provide those prerequisites completely. By understanding how challenges in device development were overcome in the past, new insights into future improvements are given. ARTICLE HISTORY

show abstract

Closure of ostium secundum atrial septum defect with the Atriasept occluder: Early European experience

Abstract: Percutaneous closure of ASD ostium secundum type defects with the ATRIASEPT is safe and effective with high success rate and excellent mid-term outcome.

Cited by 17 publications

References 21 publications

Obstruction of superior vena cava flow during transcatheter atrial septal defect closure with the Atriasept ASD occluder

Obstruction of superior vena cava flow during transcatheter atrial septal defect closure with the Atriasept ASD occluder

Les communications interauriculaires chez l’enfant: diagnostic et prise en charge à propos de 49 cas aux CHU pédiatriques de Dakar

Historical developments of atrial septal defect closure devices: what we learn from the past

Contact Info

Product

Resources

About